Table 3.
The results for adult IBD care—CD across the 2006, 2008 and 2010 rounds of the UK IBD audit, whenever directly comparable
| 2006 (2074 comparable cases of which 1669 non-elective) | 2008 (2109 comparable cases of which 1638 non-elective) | 2010 (1900 comparable cases of which 1626 non-elective) | |
|---|---|---|---|
| Mortality during the admission | 27/2074 (1.3%) | 23/2109 (1.1%) | 15/1990 (0.8%) |
| Inpatients’ review by an IBD nurse during their admission | 302/1666 (18.1%) | 394/1638 (24.1%) | 650/1626 (39.9%)* |
| Anti-TNF therapy prescription during the admission? (only non-elective patients who are not already receiving anti-TNF therapy on admission) | 58/1485 (3.9%) | 77/1571 (4.9%) | 118/1468 (8%)* |
| Prophylactic heparin prescription for non-elective admissions | 933/1669 (55.9%) | 1194/1633 (73.1%) | 1400/1626 (86%)* |
| Sending stool sample for SSC and CDT in non-elective patients with diarrhoea (recorded in the first full day following admission) | SSC 290/523 (55.5%) CDT 224/523 (42.8%) |
SSC 340/516 (65.9%) CDT 307/516 (59.5%) |
SSC 470/774 (60.7%)* CDT 426/767 (55.5%)* |
| Dietician review of non-elective patients during the admission | 465/1669 (27.9%) | 461/1638 (28.1%) | 583/1626 (35.9%)* |
| Laproscopic or laproscopically assisted surgery for non-responding elective patients | 47/374 (12.6%) | 122/460 (26.5%) | 147/361 (40.7%)* |
| Laproscopic or laproscopically assisted surgery for non-responding non-elective patients | 32/364 (8.8%) | 48/320 (15%) | 61/298 (20.5%)* |
Any statistically significant change is represented by an asterix to the right of the 2010 data column.
CD, Crohn's disease; CDT, C difficile toxin; IBD, inflammatory bowel disease; SSC, standard stool culture; TNF, tumour necrosis factor.